User:Jukeboksi/Wiki.study/Natural therapeutics: Difference between revisions

In 2018 [[w:Insys Therapeutics|Insys Therapeutics]] announced the the [[w:Food and Drug Administration|FDA]] has given CBD an [[w:orphan drug|orphan drug]] designation (ODD) to CBD for treating gliomas.<ref name="WPHealth2018glioma">http://wphealth.cc/2018/10/11/fda-approves-cannabis-for-brain-cancer-treatment/</ref>

* [https://www.frontiersin.org/articles/10.3389/fnint.2018.00051/full#h4 'Cannabis Therapeutics and the Future of Neurology: Cannabis and Brain Tumors'], a 2018 perspective article published in Frontiers in Integrative Neuroscience by [[w:Frontiers Media]]

* [http://www.ncbi.nlm.nih.gov/pubmed/20307616 'Opposite changes in cannabinoid CB1 and CB2 receptor expression in human gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 '''comparative study''', published in [[w:Neurochemistry International]]

* [http://www.ncbi.nlm.nih.gov/pubmed/20090845 'The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2010 study published in [[w:PLOS One]] on [[w:astrocytomas]] and cannabis receptors

* [http://www.ncbi.nlm.nih.gov/pubmed/17675107 'Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 '''clinical trial''', published in [[w:Neuropharmacology (journal)]]

* [http://www.ncbi.nlm.nih.gov/pubmed/19480992 'Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2009 study, published in [[w:Brain Research Bulletin]]

* [http://www.ncbi.nlm.nih.gov/pubmed/17952650 'Cannabinoids and gliomas' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2007 '''review''', published in [[w:Molecular Neurobiology (journal)]]

* [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576089 'Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, 2005 study, published in [[w:British Journal of Pharmacology]]

* [http://www.ncbi.nlm.nih.gov/pubmed/15275820 'Hypothesis: cannabinoid therapy for the treatment of gliomas?' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2004 '''review''', published in [[w:Neuropharmacology (journal)]]

* [http://www.ncbi.nlm.nih.gov/pubmed/14617682 'Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2004 study, published in [[w:Journal of Pharmacology and Experimental Therapeutics]]

* [http://www.ncbi.nlm.nih.gov/pubmed/11479216 'Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor' at ncbi.nlm.nih.gov]<ref group="1st seen in" name="trueactivist.com 2017"/>, a 2001 study published in [[w:Cancer Research (journal)]]